PDEX Pro-Dex Inc: Accounting Value per Share

Stable medical contracts generate a powerful cash flow, supporting asset growth. This chart of book value per share demonstrates this trend, where the 15.07 metric determines this level. Pro-Dex, Inc. (PDEX) revenues are based on the sale of surgical motion control systems. High patent barriers and strict FDA compliance provide the company with a sustainable competitive advantage in the market.

Pro-Dex Inc (PDEX) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for pro-dex.com (PDEX)

- price and consensus price forecast:

Stock Price Pro-Dex Corp|PDEX - Average Forecast Price

- market capitalization data:

Market Valuation Pro-Dex, Inc.|PDEX - Business Value

- book capitalization data:

Net Assets per Single Share Pro-Dex|PDEX - Company Net Assets|Market Capitalization to Book Value Ratio pro-dex.com|PDEX - Company Assets

- debt and liquidity data:

Total Debt to Capital Pro-Dex, Inc.|PDEX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Pro-Dex|PDEX - Company Total Debt Obligations|Debts to Book Capitalization Pro-Dex, Inc.

Analysis of all company metrics:Pro-Dex Corp - PDEX

Investors are verifying the issuer's financial stability through equity dynamics to assess the intrinsic value of the business. By analyzing the book value per share indicator, you can see the ratio of net equity to the number of shares; for Pro-Dex, Inc. (PDEX), the growth of this metric confirms the effective capitalization of profits generated through pricing power in the high-precision micro-drive segment for critical surgery.

Competitors of Pro-Dex, Inc. (PDEX)